Stay updated on Pyrotinib Adjuvant Study in HER-2+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Pyrotinib Adjuvant Study in HER-2+ Breast Cancer Clinical Trial page.
Latest updates to the Pyrotinib Adjuvant Study in HER-2+ Breast Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedNo new additions were noted, but a significant section of content related to downloading data formats and selecting study fields has been removed.SummaryDifference14%
- Check22 days agoNo Change Detected
- Check30 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new download options in various file formats and enhanced data field selection for studies.SummaryDifference16%
- Check37 days agoChange DetectedThe website has been updated from version v2.12.0 to v2.12.1.SummaryDifference0.3%
- Check44 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.SummaryDifference0.7%
- Check66 days agoChange DetectedThe website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.SummaryDifference0.3%
Stay in the know with updates to Pyrotinib Adjuvant Study in HER-2+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pyrotinib Adjuvant Study in HER-2+ Breast Cancer Clinical Trial page.